Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07791576
PHASE2

Population PK-guided ATG Dosing in Haplo-HSCT

Sponsor: Chinese PLA General Hospital

View on ClinicalTrials.gov

Summary

To evaluate the safety and efficacy of a population pharmacokinetics (PK)-guided targeted ATG dosing strategy in haploidentical stem cell transplantation and to observe the GVHD-free, relapse-free survival (GRFS) in the cohort receiving this strategy.

Official title: Pharmacokinetic Guided ATG Targeted Dosing Strategy in Unmanipulated Haploidentical Haematopoietic Stem-cell Transplantation

Key Details

Gender

All

Age Range

14 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

63

Start Date

2025-05-10

Completion Date

2027-12-30

Last Updated

2026-08-28

Healthy Volunteers

No

Interventions

DRUG

Anti Thymocyte Globulin

Population pharmacokinetic formula-guided targeted ATG dosing plus classical GVHD prophylaxis regimen

Locations (1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, China